Trial
NCT01632566
A Multiple-dose Study of LY3031207 in Healthy Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Healthy Volunteers
Intervention
Placebo
Why stopped
Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-27